Cassava Sciences to Present at SVB Leerink Global Healthcare Conference
AUSTIN, Texas, Feb. 23, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company developing product candidates for Alzheimer’s disease, has been invited …
Discussion disabled.
Category: Dementia